131I treatment for thyroid cancer in patients under haemodialysis (HD)

被引：0
|
作者：
Magri, G. C. [1 ]
De Agostini, A.
Movili, E. [2 ,3 ]
Gabanelli, S. V. [4 ]
Merli, G. [4 ]
Rodella, C. A.
Caobelli, F. [4 ]
Jeannin, G. [2 ,3 ]
Zubani, R. [2 ,3 ]
Giubbini, R. [4 ]
机构：
[1] Spedali Civil Brescia, Dpt Nucl Med, I-25125 Brescia, Italy
[2] Univ Brescia, Div Nephrol, I-25121 Brescia, Italy
[3] Univ Brescia, Chair Nephrol, I-25121 Brescia, Italy
[4] Univ Brescia, Chair Nucl Med, I-25121 Brescia, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S411 / S411
页数：1
相关论文
共 50 条
  • [41] Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I
    Rini, JN
    Vallabhajosula, S
    Zanzonico, P
    Hurley, JR
    Becker, DV
    Goldsmith, SJ
    THYROID, 1999, 9 (04) : 347 - 352
  • [42] ATA guidelines:: Do patients with stage I thyroid cancer benefit from 131I?
    McDougall, I. Ross
    Hay, Ian D.
    THYROID, 2007, 17 (06) : 595 - 596
  • [43] 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
    Lin, Chien-Mu
    Doyle, Pat
    Tsan, Yu-Tse
    Lee, Chang-Hsing
    Wang, Jung-Der
    Chen, Pau-Chung
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 253 - 259
  • [44] Advances in Antioxidant Applications for Combating 131I Side Effects in Thyroid Cancer Treatment
    Yang, Li
    Ma, Jiahui
    Lei, Pengyu
    Yi, Jia
    Ma, Yilei
    Huang, Zhongke
    Wang, Tingjue
    Ping, Haiyan
    Ruan, Danping
    Sun, Da
    Pan, Hongying
    TOXICS, 2023, 11 (06)
  • [45] Effects of recombinant human thyroid stimulating hormone on 131I therapy for the treatment of differentiated thyroid cancer
    Guo, Yiling
    Zhang, Yingnan
    Chen, Zuowei
    Xin, Zhenfu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (05) : 1847 - 1850
  • [46] 131I treatment in Differentiated Thyroid Cancer and End-Stage Renal Disease
    Ortega, A. J. M.
    Vazquez, R. G.
    Cuenca, J. I. C.
    Brocca, M. A. M.
    Castilla, J.
    Martinez, J. M. M.
    Gonzalez, E. N.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (01): : 29 - 33
  • [47] 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study
    Chien-Mu Lin
    Pat Doyle
    Yu-Tse Tsan
    Chang-Hsing Lee
    Jung-Der Wang
    Pau-Chung Chen
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 253 - 259
  • [48] DIURETIC AUGMENTATION OF 131I UPTAKE IN INOPERABLE THYROID CANCER
    HAMBURGE.JI
    MEIER, DA
    JOURNAL OF NUCLEAR MEDICINE, 1969, 10 (06) : 340 - &
  • [49] Radioiodide (131I) therapy for the treatment of canine thyroid carcinoma
    Worth, AJ
    Zuber, RM
    Hocking, M
    AUSTRALIAN VETERINARY JOURNAL, 2005, 83 (04) : 208 - 214
  • [50] Thyroid carcinoma with high levels of function:: Treatment with 131I
    Sisson, JC
    Carey, JE
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (06) : 975 - 983
12345